Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1465-1478
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1465
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1465
Figure 5 Human β-defensin-1 inhibits phosphorylated mTOR expression in SW620 cells.
A: Western blot analysis demonstrated that the addition of MHY1485 (mTOR activator) increased p-mTOR (Ser2448) expression and reduced Beclin-1 and LC3II/I expression in SW620 cells; B-D: Relative expression of p-mTOR, Beclin-1, and LC3II/I. aP < 0.05 vs control group; bP < 0.05 vs human β-defensin-1 group; cP < 0.05 vs MHY1485 group. P < 0.05 was considered statistically significant.
- Citation: Zhao YX, Cui Y, Li XH, Yang WH, An SX, Cui JX, Zhang MY, Lu JK, Zhang X, Wang XM, Bao LL, Zhao PW. Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506. World J Gastrointest Oncol 2024; 16(4): 1465-1478
- URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1465.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1465